BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹632.45
- Market cap
- ₹6,728 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 41.7×Sector 37.9×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Regulatory Approval
Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.
Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY
Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.3 Cr · +86.4% YoY
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.
Other capital structure change announcements
All →DCW Capital Structure Change
DCW Limited reported buying back 125,697 equity shares on 5 November 2026 at an average price of Rs 46.84 through the open market. Cumulative shares bought back under the programme reached 4,35,798.
- Value
- ₹0.59 Cr
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 1,00,000 shares on NSE on 5 November 2026 at an average Rs.111.49. The cumulative buyback stands at 1,07,40,000 shares.
- Value
- ₹1.11 Cr
Atul Capital Structure Change
Atul Ltd bought back 9,500 shares on November 5, 2026, utilising ₹5.02 Crore. Cumulative buy-back stands at 30,700 shares and ₹15.84 Crore utilised.
- Value
- ₹5.02 Cr
Arvind Fashions Capital Structure Change
Arvind Fashions disclosed that NCLT Ahmedabad approved writing off Rs. 1,438.79 Cr of securities premium in its wholly owned subsidiary Arvind Lifestyle Brands against accumulated losses. The company says this is an internal capital restructuring with no effect on net worth.
Emerald Leisures Capital Structure Change
Emerald Leisures Limited's Rights Issue Committee approved the draft letter of offer for a rights issue of up to ₹130 Crore. The issue remains subject to regulatory and statutory approvals.
- Value
- ₹130.0 Cr
Bharat Forge Capital Structure Change
Bharat Forge Limited has approved a cash investment of Rs. 290.51 Crore in its wholly-owned subsidiary, Kalyani Strategic Systems Limited. The funds will support capital expenditure and product development in the defense sector.
- Value
- ₹290.5 Cr
- Execution
- By March 31, 2027